Statement of Operations |
10 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
$ / shares
shares
| |
| Formation, general, and administrative costs | $ 386,767 |
| Advisory fee expense | 6,900,000 |
| Loss from operations | (7,286,767) |
| Other income: | |
| Dividend and interest earned on investments held in Trust Account | 5,449,992 |
| Net income (loss) | $ (1,836,775) |
| Class A Ordinary Shares | |
| Other income: | |
| Weighted average shares outstanding Basic (in Shares) | shares | 16,107,661 |
| Diluted weighted average Ordinary Shares outstanding | shares | 16,107,661 |
| Basic net loss per share (in Dollars per share) | $ / shares | $ (0.08) |
| Diluted net loss per share (in Dollars per share) | $ / shares | $ (0.08) |
| Class B Ordinary Shares | |
| Other income: | |
| Weighted average shares outstanding Basic (in Shares) | shares | 5,520,161 |
| Diluted weighted average Ordinary Shares outstanding | shares | 5,662,903 |
| Basic net loss per share (in Dollars per share) | $ / shares | $ (0.08) |
| Diluted net loss per share (in Dollars per share) | $ / shares | $ (0.08) |
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|